Publication: 3660

CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer

Citation:: J Clin Oncol vol 40 (12) 1323-1334

Year:: 2022
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Long-Term-Followup
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No
Book Volume:: 11

Parents:: 2151 2371 2539 3079 3139 3392
Children:: None

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:: Genentech
Grants:: U10CA180821, U10CA180882, U24CA196171, UG1CA189858, UG1CA233180, UG1CA233253, UG1CA233290, UG1CA233327, UG1CA233339, UG1CA233373, P30CA033572, P50CA58223, U10CA180888 (SWOG)

Corr. Author:
Authors:: Jonathan H. Shepherd Karla Ballman Mei-Yin C. Polley Jordan D. Campbell Cheng Fan Sara Selitsky Aranzazu Fernandez-Martinez Joel S. Parker Katherine A. Hoadley Zhiyuan Hu Yan Li Matthew G. Soloway Patricia A. Spears Baljit Singh Sara M. Tolaney George Somlo Elisa R. Port Cynthia Ma Charles Kuzma Eleftherios Mamounas Mehra Golshan Jennifer R. Bellon Deborah Collyar Olwen M. Hahn Clifford A. Hudis Eric P. Winer Ann Partridge Terry Hyslop Lisa A. Carey Charles M. Perou William M. Sikov

Networks:: CA043, FL086, KAISER, LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NC007, LAPS-NY016, NY021, RI005, SCOR

Study: CALGB-40603
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords:: ORIGINAL REPORTS, Breast Cancer